PremiumCompany AnnouncementsMainz Biomed’s Breakthrough in Pancreatic Cancer Detection Mainz Biomed, Liquid Biosciences make discovery of mRNA biomarkers Mainz Biomed supports Colorectal Cancer Awareness Month PremiumCompany AnnouncementsMainz Biomed Regains Nasdaq Listing Compliance Mainz Biomed regains compliance with Nasdaq Capital Market Mainz Biomed initiates U.S. study to evaluate CRC test PremiumCompany AnnouncementsMainz Biomed Secures $8 Million in Follow-On Offering Mainz Biomed NV trading resumes Mainz Biomed NV trading halted, volatility trading pause